Fig. 5
From: Identification of CLEC10A as a human lectin for pancreatic ductal adenocarcinoma
Appearance of CLEC10A-expressing monocytic cells and coexistence of CLEC10A ligand on pancreatic cancer cells are poor prognostic factors in stage II and III cases. (a) Representative images of formalin-fixed paraffin-embedded (FFPE) sections of clinical pancreatic cancer tissues stained with anti-CLEC10A antibody. Scale bars, 100 μm. Staining intensity was scored according to the number of positive cells in the 20× field of view as follows: 0 (0 fields); 1+ (1–2 fields); 2+ (> 3 fields). (b) Classification based on the combination of CLEC10A and CLEC10A ligand expression intensity. (c) Kaplan–Meier curve comparing category Low (n = 23) with category High (n = 5). Log-rank test (*P < 0.05) was used.
